- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07642531
A Modular Cloud Platform For Fertility Preservation
A Modular CLoud Based Platform To Enhance Fertility Preservation Awareness: Design, Pilot Testing And Randomized Controlled Trial
The research was designed as a randomized controlled study to determine the effectiveness of a modular cloud-based training platform in increasing awareness of fertility preservation.
The study aims to develop a free, modular, cloud-based, sustainable digital platform to increase fertility awareness. The platform will provide basic information on fertility preservation methods in plain language to support informed decisions. Content will be based on European Society of Human Reproduction and Embryology (ESHRE) , International Federation of Gynaecology and Obstetrics (FIGO) and Asian Society of Gynecologic Oncology (ASCO) guidelines. The study targets not only cancer patients but also women requesting fertility preservation for medical or social reasons.
In the first stage, the platform will be designed with the ADDIE instructional design model (Analysis, Design, Development, Implementation, Evaluation) and content created per international guidelines. In the second stage, the prototype will be pilot-tested and revised. In the third stage, effectiveness will be tested through a randomized controlled trial. Educational modules will be provided to the intervention group, while the control group will receive brochures. The study will include women aged 18-45 with early-stage gynecological cancer (cervix, ovary, tube, endometrium) at Prof. Dr. Cemil Tascioglu City Hospital, untreated. Participants must have Turkish literacy and internet access. Sample size, calculated with G*Power, is 140 total (70 per group).
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Nezihe KIZILKAYA BEJI, Professor
- Telefonnummer: 90+ 0532 502 34 94
- E-mail: nbeji@biruni.edu.tr
Undersøgelse Kontakt Backup
- Navn: Huriye Sena Kuruc, MSc
- Telefonnummer: 90+ 0531 458 13 13
- E-mail: skuruc@biruni.edu.tr
Studiesteder
-
-
Zeytinburnu
-
Istanbul, Zeytinburnu, Tyrkiet (Türkiye), 34020
- Biruni University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Women of reproductive age between the ages of 18 and 45,
- Diagnosed with early stage cervical cancer, ovarian cancer, tubal cancer and endometrial cancer and whose treatment has not started,
- Those who have a smartphone and can use the platform,
- Volunteering and giving informed consent,
- Turkish literate,
- Individuals who do not report mental problems
- Do not have children,
- Marital status is married or single.
Exclusion Criteria:
- Neurological disease (e.g., stroke, multiple sclerosis) or cognitive impairment,
- Advanced-stage gynecologic cancers,
- Failure to complete the follow-up period,
- Initiation of oncologic treatment during the study period,
- Non-completion or incomplete completion of the data collection instruments,
- Non-use of the platform among participants allocated to the intervention group,
- History of prior cancer treatment.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Control- Routine information
The control group will be given an educational brochure with similar features for fertility preservation.
|
|
|
Eksperimentel: İntervention- Using the educational platform
Prof. Dr. Cemil Taşçıoğlu City Hospital will divide female patients of reproductive age (18-45 years) who have been diagnosed with gynecological cancer (early-stage cervical, ovarian, tubal, and endometrial cancer) and have not yet started treatment, and who have been referred for egg/ovarian tissue/embryo freezing, into two groups.
The intervention group will use the cloud-based sustainable education platform developed for fertility preservation within the scope of the study.
The control group will be given an educational brochure with similar features for fertility preservation.
|
In this study, a modular cloud-based platform will be developed to raise awareness about fertility preservation.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Awareness rates regarding fertility preservation options among patients in the experimental and control groups
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
|
These data will be obtained through the answers given to the "Awareness status questionnaire for fertility protection".
|
Change from beginning of the study and after 3 weeks of after the mobile application is given
|
|
Acceptance of fertility preservation
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
|
number of patients undergoing fertility preservation procedures
|
Change from beginning of the study and after 3 weeks of after the mobile application is given
|
|
fertility preservation knowledge scores
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
|
The Fertility Health Knowledge Scale was developed to evaluate individuals' level of knowledge about fertility health; The Turkish validity and reliability study of the scale was conducted.
In this study, the knowledge level of the participants regarding fertility/fertility preservation will be evaluated based on the knowledge score using the scale in question.
|
Change from beginning of the study and after 3 weeks of after the mobile application is given
|
|
fertility preservation attitude scores
Tidsramme: Change from beginning of the study and after 3 weeks of after the mobile application is given
|
The Attitudes Toward Fertility and Childbearing Scale was developed to evaluate the attitudes of women who have not yet become mothers towards fertility and childbearing.
The Turkish validity and reliability study of the scale was conducted.
In this study, participants' attitude scores (sub-dimensions and total attitude level) towards fertility and childbearing will be evaluated using the scale in question.
|
Change from beginning of the study and after 3 weeks of after the mobile application is given
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Nezihe KIZILKAYA BEJI, Professor, Biruni University
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- KAD-FR-42
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .